|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: TCSI CORP, 10-Q, EX-10.37, 2000-11-13 |
Next: VERTEX PHARMACEUTICALS INC / MA, 10-Q, 2000-11-13 |
<TABLE> <S> <C>
<ARTICLE> 5
<MULTIPLIER> 1,000
<S> <C> <C>
<PERIOD-TYPE> 3-MOS 9-MOS
<FISCAL-YEAR-END> DEC-31-2000 DEC-31-2000
<PERIOD-START> JUL-01-2000 JAN-01-2000
<PERIOD-END> SEP-30-2000 SEP-30-2000
<CASH> 23,487 23,487
<SECURITIES> 12,158 12,158
<RECEIVABLES> 3,581 3,581
<ALLOWANCES> 859 859
<INVENTORY> 0 0
<CURRENT-ASSETS> 39,885 39,885
<PP&E> 31,337 31,337
<DEPRECIATION> 25,007 25,007
<TOTAL-ASSETS> 49,349 49,349
<CURRENT-LIABILITIES> 6,688 6,688
<BONDS> 0 0
0 0
0 0
<COMMON> 2,314 2,314
<OTHER-SE> 40,347 40,347
<TOTAL-LIABILITY-AND-EQUITY> 49,349 49,349
<SALES> 0 0
<TOTAL-REVENUES> 3,848 14,634
<CGS> 0 0
<TOTAL-COSTS> 1,795 6,558
<OTHER-EXPENSES> 1,863 7,797
<LOSS-PROVISION> 0 0
<INTEREST-EXPENSE> 0 0
<INCOME-PRETAX> (2,593) (8,188)
<INCOME-TAX> 0 0
<INCOME-CONTINUING> (2,593) (8,188)
<DISCONTINUED> 0 0
<EXTRAORDINARY> 0 0
<CHANGES> 0 0
<NET-INCOME> (2,593) (8,188)
<EPS-BASIC> (0.11) (0.36)
<EPS-DILUTED> (0.11) (0.36)
</TABLE>
|
|